[an error occurred while processing this directive]
Review

SMARCAL1, roles and mechanisms in genome stability maintenance

Expand
  • 1. Department of Pharmacology, Medical College of Hebei University, Baoding 071000, China
    2. School of Life Science, Beijing Institute of Technology, Beijing 100081, China
    3. School of Chemistry and Environmental Science, Hebei University, Baoding 071000, China

Received date: 2019-07-07

  Revised date: 2019-09-04

  Online published: 2019-09-18

Supported by

Supported by the Beijing Natural Science Foundation No(5132014);and the Hebei Provincial Key Research Programs for Medical Science No(20160051)

Abstract

SMARCAL1 is an ATP-driven DNA annealing helicase that is similar in structure to the chromatin regulators in the subfamily A group of the SWI/SNF-related matrix-associated actin-dependent chromatin regulators. SMARCAL1 catalyzes the formation of dsDNA by annealing the single-stranded binding protein RPA coated ssDNA with its complementary strand both in vitro and in vivo. In humans, different mutations of Smarcal1 gene are found to be closely related to different symptoms shown in individuals with Schimke immuno-osseous dysplasia (SIOD). This paper reviews the recent research progress of SMARCAL1 functions in remodeling DNA replication forks at damaged DNA sites, working in classical non-homologous end joining (NHEJ) repair of DNA double-stranded breaks, and in maintaining chromosomal telomere integrity. The relationships between the mutations of Smarcal1 gene in different SIOD symptoms, and the possible involvements of SMARCAL1 in neuromuscular degenerative diseases associated with trinucleotide repeats expansions are also updated and discussed to better understand the roles and mechanisms of the annealing helicase in genome stability maintenance.

Cite this article

Yalei Wen, Kenao Lü, Xiaokang Xu, Xin Zhang, Liang Ding, Xuefeng Pan . SMARCAL1, roles and mechanisms in genome stability maintenance[J]. Hereditas(Beijing), 2019 , 41(12) : 1084 -1098 . DOI: 10.16288/j.yczz.19-158

References

[1] Pan XF ed . The Molecular Biology of Gene and Diseases. Beijing: Chemical Industry Press, 2014, 1-450.
[1] 潘学峰 . 基因疾病的分子生物学. 北京: 化学工业出版社, 2014, 1-450.
[2] Pan XF, Xiao P, Li HQ, Zhao DX, Duan F . The gratuitous repair on undamaged DNA misfold, DNA Repair, 2011: 401-430.
[3] Poole LA, Cortez D . Functions of SMARCAL1, ZRANB3, and HLTF in maintaining genome stability. Crit Rev Biochem Mol Biol, 2017,52(6):696-714.
[4] Bansal R, Arya V, Sethy R, Rakesh R, Muthuswami R. RecA-like domain 2 of DNA-dependent ATPase A domain, a SWI2/SNF2 protein, mediates conformational integrity and ATP hydrolysis. Biosci Rep, 2018,38(3): BSR20180568.
[5] Bansbach CE, Bétous R, Lovejoy CA, Glick GG, Cortez D . The annealing helicase SMARCAL1 maintains genome integrity at stalled replication forks. Genes Dev, 2009,23(20):2405-2414.
[6] Bétous R, Mason AC, Rambo RP, Bansbach CE, Badu- Nkansah A, Sirbu BM, Cortez D . SMARCAL1 catalyzes fork regression and Holliday junction migration to maintain genome stability during DNA replication. Genes Dev, 2012,26(2):151-162.
[7] Lugli N, Sotiriou SK, Halazonetis TD . The role of SMARCAL1 in replication fork stability and telomere maintenance. DNA Repair, 2017,56:129-134.
[8] Severino M, Giacomini T, Verrina E, Prato G, Rossi A . Reversible cerebral vasoconstriction complicating cerebral atherosclerotic vascular disease in Schimke immuno- osseous dysplasia. Neuroradiology, 2018,60(9):885-888.
[9] Driscoll R, Cimprich KA . HARPing on about the DNA damage response during replication. Genes Dev, 2009,23(20):2359-2365.
[10] Kakar S, Fang X, Lubkowska L, Zhou YN, Shaw GX, Wang YX, Kashlev M, Ji X . Allosteric activation of bacterial Swi2/Snf2 (Switch/Sucrose non-fermentable) protein RapA by RNA polymerase: biochemical and structural studies. J Biol Chem, 2015,290(39):23656-23669.
[11] Hargreaves DC, Crabtree GR . ATP-dependent chromatin remodeling: genetics, genomics and mechanisms. Cell Res, 2011,21(3):396-420.
[12] Morimoto M . Characterization of the disease pathogenesis of Schimke immuno-osseous dysplasia. University Of British Columbia, 2016: 27-46.
[13] Baradaran-Heravi A, Raams A, Lubieniecka J, Cho KS, DeHaai KA, Basiratnia M, Mari PO, Xue Y, Rauth M, Olney AH, Shago M, Choi K, Weksberg RA, Nowaczyk MJ, Wang W, Jaspers NG, Boerkoel CF. SMARCAL1 deficiency predisposes to non-Hodgkin lymphoma and hypersensitivity to genotoxic agents in vivo. Am J Med Genet A, 2012,158A(9):2204-2213.
[14] Dekel B, Metsuyanim S, Goldstein N, Pode-Shakked N, Kovalski Y, Cohen Y, Davidovits M, Anikster Y . Schimke immuno-osseous dysplasia: expression of SMARCAL1 in blood and kidney provides novel insight into disease phenotype. Pediatr Res, 2008,63(4):398-403.
[15] Haokip, Thangminlen D, Kumari . Human SMARCAL1-a member of the SWI2/SNF2 family-is required for cell division. Faseb J, 2011,25(12):3515-3524.
[16] Elizondo LI, Cho KS, Zhang W, Yan J, Huang C, Huang Y, Choi K, Sloan EA, Deguchi K, Lou S, Baradaran- Heravi A, Takashima H, Lücke T, Quiocho FA, Boerkoel CF . Schimke immuno-osseous dysplasia: SMARCAL1 loss-of-function and phenotypic correlation. J Med Genet, 2009,46(1):49-59.
[17] Patne K, Rakesh R, Arya V, Chanana UB, Sethy R, Swer PB, Muthuswami R . BRG1 and SMARCAL1 transcriptionally co-regulate DROSHA, DGCR8 and DICER in response to doxorubicin-induced DNA damage. Biochim Biophys Acta Gene Regul Mech, 2017,1860(9):936-951.
[18] Baradaran-Heravi A, Lange J, Asakura Y, Cochat P, Massella L, Boerkoel CF . Bone marrow transplantation in Schimke immuno‐osseous dysplasia. Am J Med Genet A, 2013,161A(10):2609-2613.
[19] Zhang L, Fan S, Liu H, Huang C . Targeting SMARCAL1 as a novel strategy for cancer therapy. Biochem Biophys Res Commun, 2012,427(2):232-235.
[20] Carroll C, Hunley TE, Guo Y, Cortez D . A novel splice site mutation in SMARCAL1 results in aberrant exon definition in a child with schimke immunoosseous dysplasia. Am J Med Genet A, 2015,167A(10):2260-2264.
[21] Prato G, Grandis ED, Mancardi MM, Croci C, Pisciotta D, Uccella S, Costanzo C, Severino S, Tortora D, Pavanello M, Venesellividovits E . Schimke Immuno-osseous dysplasia: a peculiar EEG pattern. Neuropediatrics, 2018,49(S 01):S1-S12.
[22] Yusufzai T, Kadonaga JT . HARP is an ATP-driven annealing helicase. Science, 2008,322(5902):748-750.
[23] Ghosal G, Yuan J, Chen J . The HARP domain dictates the annealing helicase activity of HARP/SMARCAL1. EMBO Rep, 2011,12(6):574-580.
[24] Ciccia A, Bredemeyer AL, Sowa ME, Terret ME, Jallepalli PV, Harper JW, Elledge SJ . The SIOD disorder protein SMARCAL1 is an RPA-interacting protein involved in replication fork restart. Genes Dev, 2009,23(20):2415-2425.
[25] Hauk G, Bowman GD . Structural insights into regulation and action of SWI2/SNF2 ATPases. Curr Opin Struct Biol, 2011,21(6):719-727.
[26] Aydin ?Z, Vermeulen W, Lans H . ISWI chromatin remodeling complexes in the DNA damage response. Cell Cycle, 2014,13(19):3016-3025.
[27] Kohashi K, Yamamoto H, Yamada Y, Kinoshita I, Taguchi T, Iwamoto Y, Oda Y . SWI/SNF Chromatin-remodeling Complex Status in SMARCB1/INI1-preserved Epithelioid Sarcoma. Am J Surg Pathol, 2018,42(3):312-318.
[28] Han JJ, Song ZT, Sun JL, Yang ZT, Xian MJ, Wang S, Sun L, Liu JX . Chromatin remodeling factor CHR18 interacts with replication protein RPA1A to regulate the DNA replication stress response in Arabidopsis. New Phytol, 2018,220(2):476-487.
[29] Bétous R, Couch FB, Mason AC, Eichman BF, Manosas M, Cortez D . Substrate-selective repair and restart of replication forks by DNA translocases. Cell Rep, 2013,3(6):1958-1969.
[30] 芦广庆, 段金志, 张昱 . 哺乳动物DNA连接酶在DNA双链断裂修复通路中的作用. 遗传, 2016,38(2):178-179.
[31] Maréchal A, Zou L . RPA-coated single-stranded DNA as a platform for post-translational modifications in the DNA damage response. Cell Res, 2015,25(1):9-23.
[32] Holsclaw JK, Sekelsky J . Annealing of complementary DNA sequences during Double-Strand Break repair in Drosophila is mediated by the ortholog of SMARCAL1. Genetics, 2017,206(1):467-480.
[33] Bhat KP, Bétous R, Cortez D . High-affinity DNA-binding domains of replication protein A (RPA) direct SMARCAL1- dependent replication fork remodeling. J Biol Chem, 2015,290(7):4110-4117.
[34] Oakley GG, Patrick SM . Replication protein A: directing traffic at the intersection of replication and repair. Front Biosci, 2010,15:883-900.
[35] Xie S, Lu Y, Jakoncic J, Sun H, Xia J, Qian C . Structure of RPA32 bound to the N-terminus of SMARCAL1 redefines the binding interface between RPA32 and its interacting proteins. FEBS J, 2014,281(15):3382-3396.
[36] Sotiriou SK, Kamileri I, Lugli N, Evangelou K, Da-Ré C, Huber F, Padayachy L, Tardy S, Nicati NL, Barriot S, Ochs F, Lukas C, Lukas J, Gorgoulis VG, Scapozza L, Halazonetis TD . Mammalian RAD52 functions in break-induced replication repair of collapsed DNA replication Forks. Mol Cell, 2016,64(6):1127-1134.
[37] Feldkamp MD, Mason AC, Eichman BF, Chazin WJ . Structural analysis of replication protein A recruitment of the DNA damage response protein SMARCAL1. Biochemistry, 2014,53(18):3052-3061.
[38] Lovejoy CA, Cortez D . Common mechanisms of PIKK regulation. DNA Repair, 2009,8(9):1004-1008.
[39] Couch FB, Bansbach CE, Driscoll R, Luzwick JW, Glick GG, Bétous R, Carroll CM, Jung SY, Qin J, Cimprich KA, Cortez D . ATR phosphorylates SMARCAL1 to prevent replication fork collapse. Genes Dev, 2013,27(14):1610-1623.
[40] Bétous R, Glick GG, Zhao R, Cortez D . Identification and characterization of SMARCAL1 protein complexes. PLoS One, 2013,8(5):e63149.
[41] Atkinson J, McGlynn P. Replication fork reversal and the maintenance of genome stability. Nucleic Acids Res, 2009,37(11):3475-3492.
[42] Neelsen KJ, Lopes M . Replication fork reversal in eukaryotes: from dead end to dynamic response. Nat Rev Mol Cell Biol, 2015,16(4):207-220.
[43] Margalef P, Kotsantis P, Borel V, Bellelli R, Panier S, Boulton S J . Stabilization of reversed replication forks by telomerase drives telomere catastrophe. Cell, 2018,172(3):439-453.
[44] Bianco PR, Lyubchenko YL . SSB and the RecG DNA helicase: an intimate association to rescue a stalled replication fork. Protein Sci, 2017,26(4):638-649.
[45] Wu XM, Tang WR, Luo Y . ALT-Alternative lengthening of telomere. Hereditas(Beijing) , 2009,31(12):1185-1191.
[45] 吴晓明, 唐文如, 罗瑛 . ALT-端粒延长替代机制. 遗传, 2009,31(12):1185-1191.
[46] Ying SY, Xiong JX, Mai HX, Lin JJ, Jiang LN, Cheng L, Ye QN . Advances on the regulation of telomerase. Hereditas(Beijing) , 2016,38(4):289-299
[46] 营孙阳, 熊加秀, 麦洪旭, 林佳佳, 姜丽娜, 程龙, 叶棋浓 . 端粒酶调控研究进展. 遗传, 2016,38(4):289-299.
[47] Sfeir A, Kosiyatrakul ST, Hockemeyer D, MacRae SL, Karlseder J, Schildkraut CL, de Lange T . Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication. Cell, 2009,138(1):90-103.
[48] Sobinoff AP, Pickett HA . Alternative lengthening of telomeres: DNA repair pathways converge. Trends Gene, 2017,33(12):921-932.
[49] Cox KE, Maréchal A, Flynn RL . SMARCAL1 resolves replication stress at ALT telomeres. Cell Rep, 2016,14(5):1032-1040.
[50] Poole LA, Cortez D . SMARCAL1 and telomeres: replicating the troublesome ends. Nucleus, 2016,7(3):270-274.
[51] Pannunzio NR, Watanabe G, Lieber MR . Nonhomologous DNA end-joining for repair of DNA double-strand breaks. J Biol Chem, 2018,293(27):10512-10523.
[52] Orthwein A, Fradet-Turcotte A, Noordermeer SM, Canny MD, Brun CM, Strecker J, Escribano-Diaz C, Durocher D . Mitosis inhibits DNA double-strand break repair to guard against telomere fusions. Science, 2014,344(6180):189-193.
[53] Sims J, Copenhaver GP, Schloegelhofer P . Meiotic DNA repair in the nucleolus employs a non-homologous end joining mechanism. Plant Cell, doi: https://doi.org/10.1101/553529.
[54] Lu HM, Shamanna RA, de Freitas JK, Okur M, Khadka P, Kulikowicz T, Holland PP, Tian J, Croteau DL, Davis AJ, Bohr VA . Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair. Nat Commun, 2017,8(1):2039.
[55] Keka IS, Mohiuddin , Maede Y, Rahman MM, Sakuma T, Honma M, Yamamoto T, Takeda S, Sasanuma H. Smarcal1 promotes double-strand-break repair by nonhomologous end-joining. Nucleic Acids Res, 2015,43(13):6359-6372.
[56] Mimitou EP, Symington LS . Ku prevents Exo1 and Sgs1-dependent resection of DNA ends in the absence of a functional MRX complex or Sae2. Embo J, 2010,29(19):3358-3369.
[57] Ling AK, So CC, Le MX, Chen AY, Hung L, Martin A . Double-stranded DNA break polarity skews repair pathway choice during intrachromosomal and interchromosomal recombination. Proc Natl Acad Sci USA, 2018,115(11):2800-2805.
[58] Jette N, Lees-Miller SP . The DNA-dependent protein kinase: A multifunctional protein kinase with roles in DNA double strand break repair and mitosis. Prog Biophys Mol Biol, 2015,117(2-3):194-205.
[59] Chang HHY, Pannunzio NR, Adachi N, Lieber MR . Non-homologous DNA end joining and alternative pathways to double-strand break repair. Nat Rev Mol Cell Biol, 2017,18(8):495-506.
[60] Hammel M, Yu Y, Radhakrishnan SK, Chokshi C, Tsai MS, Matsumoto Y, Kuzdovich M, Remesh SG, Fang S, Tomkinson AE, Lees-Miller SP, Tainer JA . An intrinsically disordered APLF links Ku, DNA-PKcs, and XRCC4-DNA ligase IV in an extended flexible non- homologous end joining complex. J Biol Chem, 2016,291(53):26987-27006.
[61] Hinde E, Kong X, Yokomori K, Gratton E . Chromatin dynamics during DNA repair revealed by pair correlation analysis of molecular flow in the nucleus. Biophys J, 2014,107(1):55-65.
[62] Sibanda BL, Chirgadze DY, Ascher DB, Blundell TL . DNA-PKcs structure suggests an allosteric mechanism modulating DNA double-strand break repair. Science, 2017,355(6324):520-524.
[63] Ma Y, Pannicke U, Lu H, Niewolik D, Schwarz K, Lieber MR . The DNA-dependent protein kinase catalytic subunit phosphorylation sites in human Artemis. J Biol Chem, 2005, 280(40):33839-33846.
[64] Zhou Y, Caron P, Legube G, Paull TT . Quantitation of DNA double-strand break resection intermediates in human cells. Nucleic Acids Res, 2014,42(3):e19.
[65] Yin X, Liu M, Tian Y, Wang J, Xu Y . Cryo-EM structure of human DNA-PK holoenzyme. Cell Res, 2017,27(11):1341-1350.
[66] Hiom K . Coping with DNA double strand breaks. DNA Repair, 2010,9(12):1256-1263.
[67] Shibata A, Moiani D, Arvai AS, Perry J, Harding SM, Genois MM, Maity R, van Rossum-Fikkert S, Kertokalio A, Romoli F, Ismail A, Ismalaj E, Petricci E, Neale MJ, Bristow RG, Masson JY, Wyman C, Jeggo PA, Tainer JA. DNA double-strand break repair pathway choice is directed by distinct MRE11 nuclease activities. Mol Cell, 2014,53(1):7-18.
[68] Casari E, Rinaldi C, Marsella A, Gnugnoli M, Colombo CV, Bonetti D, Longhese MP . Processing of DNA double-strand breaks by the MRX complex in a chromatin context. Front Mol Biosci, 2019,6:43.
[69] Korsholm LM, Gál Z, Lin L, Quevedo O, Ahmad DA, Dulina E, Luo YL, Bartek J, Larsen DH . Double-strand breaks in ribosomal RNA genes activate a distinct signaling and chromatin response to facilitate nucleolar restructuring and repair. Nucleic Acids Res, 2019,47(15):8019-8035.
[70] Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, Olivi A, McLendon R, Rasheed BA, Keir S, Nikolskaya T, Nikolsky Y, Busam DA, Tekleab H, Diaz LA Jr, Hartigan J, Smith DR, Strausberg RL, Marie SK, Shinjo SM, Yan H, Riggins GJ, Bigner DD, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW . An integrated genomic analysis of human glioblastoma multiforme. Science, 2008,321(5897):1807-1812.
[71] Kolinjivadi AM, Sannino V, De Antoni A, Zadorozhny K, Kilkenny M, Técher H, Baldi G, Shen R, Ciccia A, Pellegrini L, Krejci L, Costanzo V . Smarcal1-mediated fork reversal triggers Mre11-dependent degradation of nascent DNA in the absence of Brca2 and stable Rad51 nucleofilaments. Mol Cell, 2017,67(5):867-881.
[72] Levens DL . Reconstructing myc. Genes Dev, 2003,17(9):1071-1077.
[73] Barna M, Pusic A, Zollo O, Costa M, Kondrashov N, Rego E, Rao PH, Ruggero D . Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency. Nature, 2008,456(7224):971-975.
[74] Sutherland C, Cui YX, Mao HB, Hurley LH . A mechanosensor mechanism controls the G-quadruplex/ i-motif molecular switch in the MYC promoter NHE III1. J Am Chem Soc, 2016,138(42):14138-14151.
[75] Baradaran-Heravi A, Cho KS, Tolhuis B, Sanyal M, Morozova O, Morimoto M, Elizondo LI, Bridgewater D, Lubieniecka J, Beirnes K, Myung C, Leung D, Fam HK, Choi K, Huang Y, Dionis KY, Zonana J, Keller K, Stenzel P, Mayfield C, Lücke T, Bokenkamp A, Marra MA, van Lohuizen M, Lewis DB, Shaw C, Boerkoel CF. Penetrance of biallelic SMARCAL1 mutations is associated with environmental and genetic disturbances of gene expression. Hum Mol Genet, 2012,21(11):2572-2587.
[76] Sharma T, Bansal R, Haokip DT, Goel I, Muthuswami R . SMARCAL1 negatively regulates c-Myc transcription by altering the conformation of the promoter region. Sci Rep, 2015,5:17910.
[77] Pan XF . Mechanism of trinucleotide repeats instabilities: the necessities of repeat non-B secondary structure formation and the roles of cellular trans-acting factors. Yi Chuan Xue Bao, 2006,33(1):1-11.
[78] Pan XF, Jiang N, Chen XF, Zhou XH, Ding L, Duan F . R-loop structure: the formation and the effects on genomic stability. Hereditas(Beijing), 2014,36(12):1185-1194.
[78] 潘学峰, 姜楠, 陈细芳, 周晓宏, 丁良, 段斐 . R环的形成及对基因组稳定性的影响. 遗传, 2014,36(12):1185-1194.
[79] Wang XH, Pan XF, Li HQ . Advances in the studies of the expansion of (CAG) n·(CTG) n trinucleotide repeats and mecha-nisms underlying its related diseases. Int J Genet, 2016,39(15):274-281.
[79] 王希恒, 潘学峰, 李红权 . (CAG)n·(CTG)n三核苷酸重复序列扩增及相关疾病机制研究进展. 国际遗传学杂志, 2016,39(15):274-281.
[80] Kononenko AV, Ebersole T, Vasquez KM, Mirkin SM . Mechanisms of genetic instability caused by (CGG)n repeats in an experimental mammalian system. Nat Struct Mol Biol, 2018,25(8):669-676.
[81] 王晓慧, 方方, 丁昌红, 黄昱, 王旭, 李楠 . Schimke免疫-骨发育不良一例. 中华儿科杂志, 2015,53(8):631-632.
[82] Lücke T, Franke D, Clewing JM, Boerkoel CF, Ehrich JH, Das AM, Zivicnjak M . Schimke versus non-Schimke chronic kidney disease: an anthropometric approach. Pediatrics, 2006,118(2):e400-407.
[83] Gupta M, Mazumder M, Dhatchinamoorthy K, Nongkhlaw M, Haokip DT, Gourinath S, Komath SS, Muthuswami R . Ligand-induced conformation changes drive ATP hydrolysis and function in SMARCAL1. FEBS J, 2015,282(19):3841-3859.
[84] Saraiva JM, Dinis A, Resende C, Faria E, Gomes C, Correia AJ, Gil J, da Fonseca N. Schimke immuno- osseous dysplasia: case report and review of 25 patients. J Med Genet, 1999,36(10):786-789.
[85] Boerkoel CF, O'Neill S, André JL, Benke PJ, Bogdanoví? R, Bulla M, Burguet A, Cockfield S, Cordeiro I, Ehrich JH, Fründ S, Geary DF, Ieshima A, Illies F, Joseph MW, Kaitila I, Lama G, Leheup B, Ludman MD, McLeod DR, Medeira A, Milford DV, Orm?l? T, Rener-Primec Z, Santava A, Santos HG, Schmidt B, Smith GC, Spranger J, Zupancic N, Weksberg R. Manifestations and treatment of Schimke immuno-osseous dysplasia: 14 new cases and a review of the literature. Eur J Pediatr, 2000,159(1-2):1-7.
[86] Wang W, Song H, Wei M, Qiu Z, Wang C, Zhang Y, Li M, Yuan YH, Tang XY . SMARCAL1 gene analysis of 2 Chinese Schimke immuno-osseous dysplasia children. Chin J Pediatr. 2015,53(1):45-50.
[86] 王薇, 宋红梅, 魏珉, 邱正庆, 王晨, 张玉, 李明, 袁裕衡, 唐晓艳 . Schimke免疫-骨发育不良儿童基因分析. 中华儿科杂志, 2015,53(1):45-50.
[87] Liu ZQ, Song FY, Liu Y, Qiu MF, Qian Y, Chen XB . Schimke immuno-osseous dysplasia (SIOD): A case report and review of literatures. Chin J Endocrinol Metabolism. 2017,33(2):111-115.
[87] 刘子勤, 宋福英, 刘颖, 邱明芳, 钱晔, 陈晓波 . Schimke免疫-骨发育不良一例并文献复习. 中华内分泌代谢杂志, 2017,33(2):111-115.
[88] Liu SM, Zhang MC, Ni MX, Zhu PR, Xia XY . A novel compound heterozygous mutation of the SMARCAL1 gene leading to mild Schimke immune-osseous dysplasia: a case report. BMC Pediatr, 2017,17(1):217.
[89] Barraza-García J, Rivera-Pedroza CI, Belinchón A, Fernández-Camblor C, Valenciano-Fuente B, Lapunzina P, Heath KE . A novel SMARCAL1 missense mutation that affects splicing in a severely affected Schimke immunoosseous dysplasia patient. Eur J Med Genet, 2016,59(8):363-366.
[90] Santangelo L, Gigante M, Netti GS, Diella S, Puteo F, Carbone V, Gesualdo L . A novel SMARCAL1 mutation associated with a mild phenotype of Schimke immuno- osseous dysplasia (SIOD). BMC Nephrol, 2014,15(1):41.
[91] Carroll C, Badu-Nkansah A, Hunley T, Baradaran- Heravi A, Cortez D, Frangoul H . Schimke Immunoosseous Dysplasia associated with undifferentiated carcinoma and a novel SMARCAL1 mutation in a child. Pediatr Blood Cancer, 2013,60(9):E88-90.
[92] Yue Z, Xiong S, Sun L, Huang W, Mo Y, Huang L, Jiang X, Chen S, Hu B, Wang Y . Novel compound mutations of SMARCAL1 associated with severe Schimke immuno- osseous dysplasia in a Chinese patient . Nephrol Dial Transplant, 2010,25(5):1697-1702.
[93] B?kenkamp A, deJong M, van Wijk JA, Block D, van Hagen JM, Ludwig M . R561C missense mutation in the SMARCAL1 gene associated with mild Schimke immuno- osseous dysplasia. Pediatr Nephrol, 2005,20(12):1724-1728.
[94] Zivicnjak M, Franke D, Zenker M, Hoyer J, Lücke T, Pape L, Ehrich JH . SMARCAL1 mutations: a cause of prepubertal idiopathic steroid-resistant nephrotic syndrome. Pediatr Res, 2009,65(5):564-568.
[95] Kilic SS, Donmez O, Sloan EA, Elizondo LI, Huang C, André JL, Bogdanovic R, Cockfield S, Cordeiro I, Deschenes G, Fründ S, Kaitila I, Lama G, Lamfers P, Lücke T, Milford DV, Najera L, Rodrigo F, Saraiva JM, Schmidt B, Smith GC, Stajic N, Stein A, Taha D, Wand D, Armstrong D, Boerkoel CF . Association of migraine- like headaches with Schimke immuno-osseous dysplasia. Am J Med Genet A, 2005,135(2):206-210.
[96] Simon AJ, Lev A, Jeison M, Borochowitz ZU, Korn D, Lerenthal Y, Somech R . Novel SMARCAL1 bi-allelic mutations associated with a chromosomal breakage phenotype in a severe SIOD patient. J Clin Immunol, 2014,34(1):76-83.
[97] Boerkoel CF, Takashima H, John J, Yan J, Stankiewicz P, Rosenbarker L, André JL, Bogdanovic R, Burguet A, Cockfield S, Cordeiro I, Fründ S, Illies F, Joseph M, Kaitila I, Lama G, Loirat C, McLeod DR, Milford DV, Petty EM, Rodrigo F, Saraiva JM, Schmidt B, Smith GC, Spranger J, Stein A, Thiele H, Tizard J, Weksberg R, Lupski JR, Stockton DW. Mutant chromatin remodeling protein SMARCAL1 causes Schimke immuno-osseous dysplasia. Nat Genet, 2002,30(2):215-220.
[98] Meek K, Gupta S, Ramsden DA, Lees-Miller SP . The DNA-dependent protein kinase: the director at the end. Immunol Rev, 2004,200:132-141.
[99] Buck D, Moshous D, de Chasseval R, Ma Y, le Deist F, Cavazzana-Calvo M, Fischer A, Casanova JL, Lieber MR, de Villartay JP . Severe combined immunodeficiency and microcephaly in siblings with hypomorphic mutations in DNA ligase IV. Eur J Immunol, 2006,36(1):224-235.
[100] Lev A, Amariglio N, Levy Y, Spirer Z, Anikster Y, Rechavi G, Dekel B, Somech R . Molecular assessment of thymic capacities in patients with Schimke immuno- osseous dysplasia. Clin Immunol, 2009,133(3):375-381.
[101] Dutta P, Tanti GK, Sharma S, Goswami SK, Komath SS, Mayo MW, Hockensmith JW, Muthuswami R . Global epigenetic changes induced by SWI2/SNF2 inhibitors characterize neomycin-resistant mammalian cells. PLoS One, 2012,7(11):e49822.
Outlines

/